Global Targeted NGS Amplicon Sequencing Services Market Strategic Research Report

Scope of the Report

The global Targeted NGS Amplicon Sequencing Services market size is predicted to grow from US$ 768 million in 2025 to US$ 1,459 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

Targeted NGS Amplicon Sequencing is a targeted next-generation sequencing approach that first amplifies specific genomic regions of interest using polymerase chain reaction (PCR) to generate target amplicons, then performs high-throughput sequencing on these enriched fragments to analyze genetic variations efficiently. It focuses on predefined genomic loci such as disease-related genes, mutation hotspots or biomarker regions, bypassing whole-genome sequencing, delivering focused data output with high sequencing depth and accuracy, and enabling rapid detection of single nucleotide polymorphisms, insertions, deletions and other genetic variants.

Demand for targeted NGS amplicon sequencing is driven by the expansion of precision medicine, clinical genetic testing, infectious disease pathogen identification and agricultural genomic breeding, with stable clinical demand in oncology companion diagnostics, hereditary disease screening and microbial detection, and emerging demand in agricultural trait selection and environmental sample monitoring. Business opportunities lie in developing high-specificity amplicon panel design for rare diseases and drug resistance monitoring, optimizing library preparation workflows to reduce turnaround time and cost, launching integrated detection platforms for clinical and field applications, and expanding application scenarios in personalized health management and food safety testing.

This report presents a comprehensive overview of the global Targeted NGS Amplicon Sequencing Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Sample Type

• Blood Sample Sequencing
• Tissue Sample Sequencing
• Cell Sample Sequencing

Segment by Target Region

• Single-Gene Sequencing
• Multi-Gene Panel Sequencing
• Customized Region Sequencing

Segment by Sequencing Depth

• Low-Depth Sequencing
• Medium-Depth Sequencing
• High-Depth Sequencing

Segment by Application

• Clinical Molecular Diagnostics
• Human Genetics & Population Research
• Agricultural Biotechnology & Breeding
• Industrial Biotechnology
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Targeted NGS Amplicon Sequencing Services market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinical Molecular Diagnostics, Human Genetics & Population Research, Agricultural Biotechnology & Breeding evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact